nodes	percent_of_prediction	percent_of_DWPC	metapath
Alclometasone—Corticosteroid Hormone Receptor Agonists—Prednisone—prostate cancer	0.325	1	CiPCiCtD
Alclometasone—Prednisone—prostate cancer	0.225	1	CrCtD
Alclometasone—NR3C1—prostate cancer	0.0902	0.633	CbGaD
Alclometasone—CYP3A4—prostate cancer	0.0523	0.367	CbGaD
Alclometasone—NR3C1—Prednisone—prostate cancer	0.0229	0.187	CbGbCtD
Alclometasone—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0206	0.168	CbGbCtD
Alclometasone—CYP3A4—Bicalutamide—prostate cancer	0.0108	0.0883	CbGbCtD
Alclometasone—Ciclesonide—Prednisone—prostate cancer	0.0105	0.0694	CrCrCtD
Alclometasone—CYP3A4—Estramustine—prostate cancer	0.01	0.0821	CbGbCtD
Alclometasone—CYP3A4—Flutamide—prostate cancer	0.00895	0.0731	CbGbCtD
Alclometasone—CYP3A4—Abiraterone—prostate cancer	0.00895	0.0731	CbGbCtD
Alclometasone—Prednicarbate—Prednisone—prostate cancer	0.00828	0.0546	CrCrCtD
Alclometasone—Fluocortolone—Prednisone—prostate cancer	0.00804	0.053	CrCrCtD
Alclometasone—Budesonide—Prednisone—prostate cancer	0.00761	0.0501	CrCrCtD
Alclometasone—Diflorasone—Prednisone—prostate cancer	0.00742	0.0488	CrCrCtD
Alclometasone—Flunisolide—Prednisone—prostate cancer	0.00742	0.0488	CrCrCtD
Alclometasone—Clobetasol propionate—Prednisone—prostate cancer	0.00742	0.0488	CrCrCtD
Alclometasone—Desonide—Prednisone—prostate cancer	0.00742	0.0488	CrCrCtD
Alclometasone—Paramethasone—Prednisone—prostate cancer	0.00723	0.0476	CrCrCtD
Alclometasone—Desoximetasone—Prednisone—prostate cancer	0.00705	0.0465	CrCrCtD
Alclometasone—Fluprednidene Acetate—Prednisone—prostate cancer	0.00689	0.0454	CrCrCtD
Alclometasone—Loteprednol—Prednisone—prostate cancer	0.00689	0.0454	CrCrCtD
Alclometasone—Fluorometholone—Prednisone—prostate cancer	0.00689	0.0454	CrCrCtD
Alclometasone—Triamcinolone—Prednisone—prostate cancer	0.00689	0.0454	CrCrCtD
Alclometasone—Mometasone—Prednisone—prostate cancer	0.00689	0.0454	CrCrCtD
Alclometasone—Rimexolone—Prednisone—prostate cancer	0.00673	0.0443	CrCrCtD
Alclometasone—Dexamethasone—Prednisone—prostate cancer	0.00673	0.0443	CrCrCtD
Alclometasone—Betamethasone—Prednisone—prostate cancer	0.00673	0.0443	CrCrCtD
Alclometasone—CYP3A4—Cabazitaxel—prostate cancer	0.00662	0.0541	CbGbCtD
Alclometasone—CYP3A4—Estrone—prostate cancer	0.00647	0.0529	CbGbCtD
Alclometasone—Methylprednisolone—Prednisone—prostate cancer	0.00644	0.0424	CrCrCtD
Alclometasone—Prednisolone—Prednisone—prostate cancer	0.0063	0.0415	CrCrCtD
Alclometasone—Hydrocortisone—Prednisone—prostate cancer	0.00605	0.0398	CrCrCtD
Alclometasone—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00577	0.0471	CbGbCtD
Alclometasone—CYP3A4—Conjugated Estrogens—prostate cancer	0.00424	0.0346	CbGbCtD
Alclometasone—CYP3A4—Mitoxantrone—prostate cancer	0.00385	0.0314	CbGbCtD
Alclometasone—CYP3A4—Estradiol—prostate cancer	0.00372	0.0304	CbGbCtD
Alclometasone—CYP3A4—Prednisone—prostate cancer	0.0032	0.0261	CbGbCtD
Alclometasone—CYP3A4—Etoposide—prostate cancer	0.00243	0.0198	CbGbCtD
Alclometasone—CYP3A4—Docetaxel—prostate cancer	0.00222	0.0181	CbGbCtD
Alclometasone—CYP3A4—Doxorubicin—prostate cancer	0.00166	0.0135	CbGbCtD
Alclometasone—Allergic contact dermatitis—Estradiol—prostate cancer	0.000688	0.0563	CcSEcCtD
Alclometasone—NR3C1—urine—prostate cancer	0.000581	0.209	CbGeAlD
Alclometasone—Acneiform eruption—Prednisone—prostate cancer	0.000529	0.0432	CcSEcCtD
Alclometasone—Skin atrophy—Prednisone—prostate cancer	0.000442	0.0362	CcSEcCtD
Alclometasone—CYP3A4—urine—prostate cancer	0.00044	0.158	CbGeAlD
Alclometasone—Skin striae—Prednisone—prostate cancer	0.00042	0.0343	CcSEcCtD
Alclometasone—Dermatitis acneiform—Prednisone—prostate cancer	0.000391	0.032	CcSEcCtD
Alclometasone—Secondary infection—Epirubicin—prostate cancer	0.000355	0.0291	CcSEcCtD
Alclometasone—Secondary infection—Doxorubicin—prostate cancer	0.000329	0.0269	CcSEcCtD
Alclometasone—SERPINA6—renal system—prostate cancer	0.000325	0.117	CbGeAlD
Alclometasone—Leukoderma—Prednisone—prostate cancer	0.000314	0.0257	CcSEcCtD
Alclometasone—Erythema—Flutamide—prostate cancer	0.000263	0.0215	CcSEcCtD
Alclometasone—Leukoderma—Epirubicin—prostate cancer	0.000246	0.0201	CcSEcCtD
Alclometasone—SERPINA6—bone marrow—prostate cancer	0.000245	0.0882	CbGeAlD
Alclometasone—Dermatitis contact—Estradiol—prostate cancer	0.000238	0.0194	CcSEcCtD
Alclometasone—Erythema—Degarelix—prostate cancer	0.000236	0.0193	CcSEcCtD
Alclometasone—Infection—Abiraterone—prostate cancer	0.000234	0.0192	CcSEcCtD
Alclometasone—Leukoderma—Doxorubicin—prostate cancer	0.000227	0.0186	CcSEcCtD
Alclometasone—Erythema—Cabazitaxel—prostate cancer	0.000222	0.0182	CcSEcCtD
Alclometasone—NR3C1—prostate gland—prostate cancer	0.000209	0.0749	CbGeAlD
Alclometasone—Infection—Cabazitaxel—prostate cancer	0.00018	0.0147	CcSEcCtD
Alclometasone—NR3C1—seminal vesicle—prostate cancer	0.000176	0.0634	CbGeAlD
Alclometasone—Pruritus—Estramustine—prostate cancer	0.000172	0.0141	CcSEcCtD
Alclometasone—Folliculitis—Epirubicin—prostate cancer	0.000166	0.0136	CcSEcCtD
Alclometasone—Pruritus—Estrone—prostate cancer	0.000164	0.0134	CcSEcCtD
Alclometasone—Infection—Bicalutamide—prostate cancer	0.000155	0.0126	CcSEcCtD
Alclometasone—Folliculitis—Doxorubicin—prostate cancer	0.000154	0.0126	CcSEcCtD
Alclometasone—NR3C1—epithelium—prostate cancer	0.000153	0.0551	CbGeAlD
Alclometasone—Rash—Estramustine—prostate cancer	0.000153	0.0125	CcSEcCtD
Alclometasone—Dermatitis—Estramustine—prostate cancer	0.000153	0.0125	CcSEcCtD
Alclometasone—Pruritus—Nilutamide—prostate cancer	0.000152	0.0125	CcSEcCtD
Alclometasone—Pruritus—Flutamide—prostate cancer	0.000152	0.0124	CcSEcCtD
Alclometasone—Rash—Abiraterone—prostate cancer	0.000149	0.0122	CcSEcCtD
Alclometasone—Dermatitis—Abiraterone—prostate cancer	0.000149	0.0121	CcSEcCtD
Alclometasone—Rash—Estrone—prostate cancer	0.000146	0.012	CcSEcCtD
Alclometasone—Dermatitis—Estrone—prostate cancer	0.000146	0.012	CcSEcCtD
Alclometasone—Pruritus—Estradiol valerate/Dienogest—prostate cancer	0.000143	0.0117	CcSEcCtD
Alclometasone—NR3C1—renal system—prostate cancer	0.000142	0.0511	CbGeAlD
Alclometasone—NR3C1—urethra—prostate cancer	0.00014	0.0502	CbGeAlD
Alclometasone—Pruritus—Degarelix—prostate cancer	0.000136	0.0111	CcSEcCtD
Alclometasone—Rash—Nilutamide—prostate cancer	0.000136	0.0111	CcSEcCtD
Alclometasone—Dermatitis—Nilutamide—prostate cancer	0.000136	0.0111	CcSEcCtD
Alclometasone—Rash—Flutamide—prostate cancer	0.000135	0.0111	CcSEcCtD
Alclometasone—Dermatitis—Flutamide—prostate cancer	0.000135	0.0111	CcSEcCtD
Alclometasone—Erythema—Goserelin—prostate cancer	0.000133	0.0108	CcSEcCtD
Alclometasone—Erythema—Conjugated Estrogens—prostate cancer	0.000131	0.0107	CcSEcCtD
Alclometasone—Infection—Ethinyl Estradiol—prostate cancer	0.000131	0.0107	CcSEcCtD
Alclometasone—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000128	0.0104	CcSEcCtD
Alclometasone—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000128	0.0104	CcSEcCtD
Alclometasone—Rash—Degarelix—prostate cancer	0.000121	0.00992	CcSEcCtD
Alclometasone—Dermatitis—Degarelix—prostate cancer	0.000121	0.00992	CcSEcCtD
Alclometasone—Pruritus—Bicalutamide—prostate cancer	0.00011	0.009	CcSEcCtD
Alclometasone—CYP3A4—renal system—prostate cancer	0.000108	0.0386	CbGeAlD
Alclometasone—Infection—Goserelin—prostate cancer	0.000108	0.00879	CcSEcCtD
Alclometasone—NR3C1—bone marrow—prostate cancer	0.000108	0.0386	CbGeAlD
Alclometasone—Infection—Conjugated Estrogens—prostate cancer	0.000107	0.00871	CcSEcCtD
Alclometasone—Erythema—Estradiol—prostate cancer	0.000105	0.0086	CcSEcCtD
Alclometasone—Dermatitis contact—Epirubicin—prostate cancer	0.000103	0.00844	CcSEcCtD
Alclometasone—Rash—Bicalutamide—prostate cancer	9.81e-05	0.00802	CcSEcCtD
Alclometasone—Dermatitis—Bicalutamide—prostate cancer	9.8e-05	0.00801	CcSEcCtD
Alclometasone—Erythema—Mitoxantrone—prostate cancer	9.8e-05	0.00801	CcSEcCtD
Alclometasone—Dermatitis contact—Doxorubicin—prostate cancer	9.55e-05	0.00781	CcSEcCtD
Alclometasone—Pruritus—Ethinyl Estradiol—prostate cancer	9.3e-05	0.00761	CcSEcCtD
Alclometasone—NR3C1—testis—prostate cancer	9.19e-05	0.033	CbGeAlD
Alclometasone—Infection—Estradiol—prostate cancer	8.52e-05	0.00697	CcSEcCtD
Alclometasone—Rash—Ethinyl Estradiol—prostate cancer	8.29e-05	0.00678	CcSEcCtD
Alclometasone—Dermatitis—Ethinyl Estradiol—prostate cancer	8.28e-05	0.00677	CcSEcCtD
Alclometasone—Infection—Mitoxantrone—prostate cancer	7.94e-05	0.00649	CcSEcCtD
Alclometasone—Pruritus—Goserelin—prostate cancer	7.66e-05	0.00626	CcSEcCtD
Alclometasone—Pruritus—Conjugated Estrogens—prostate cancer	7.58e-05	0.0062	CcSEcCtD
Alclometasone—Hydrocortisone—ANXA1—prostate cancer	7.41e-05	0.0401	CrCbGaD
Alclometasone—Dexamethasone—CYP3A43—prostate cancer	6.98e-05	0.0378	CrCbGaD
Alclometasone—Rash—Goserelin—prostate cancer	6.82e-05	0.00558	CcSEcCtD
Alclometasone—Dermatitis—Goserelin—prostate cancer	6.82e-05	0.00557	CcSEcCtD
Alclometasone—Erythema—Docetaxel—prostate cancer	6.77e-05	0.00554	CcSEcCtD
Alclometasone—Rash—Conjugated Estrogens—prostate cancer	6.76e-05	0.00553	CcSEcCtD
Alclometasone—Dermatitis—Conjugated Estrogens—prostate cancer	6.75e-05	0.00552	CcSEcCtD
Alclometasone—NR3C1—lymph node—prostate cancer	6.66e-05	0.0239	CbGeAlD
Alclometasone—Infection—Etoposide—prostate cancer	6.61e-05	0.0054	CcSEcCtD
Alclometasone—Erythema—Capecitabine—prostate cancer	6.56e-05	0.00536	CcSEcCtD
Alclometasone—Pruritus—Estradiol—prostate cancer	6.07e-05	0.00496	CcSEcCtD
Alclometasone—Erythema—Prednisone—prostate cancer	5.84e-05	0.00477	CcSEcCtD
Alclometasone—Clocortolone—NR3C1—prostate cancer	5.73e-05	0.031	CrCbGaD
Alclometasone—Prednicarbate—NR3C1—prostate cancer	5.73e-05	0.031	CrCbGaD
Alclometasone—Dexamethasone—ANXA1—prostate cancer	5.52e-05	0.0299	CrCbGaD
Alclometasone—Infection—Docetaxel—prostate cancer	5.49e-05	0.00449	CcSEcCtD
Alclometasone—Diflorasone—NR3C1—prostate cancer	5.42e-05	0.0293	CrCbGaD
Alclometasone—Desonide—NR3C1—prostate cancer	5.42e-05	0.0293	CrCbGaD
Alclometasone—Rash—Estradiol—prostate cancer	5.41e-05	0.00442	CcSEcCtD
Alclometasone—Dermatitis—Estradiol—prostate cancer	5.4e-05	0.00442	CcSEcCtD
Alclometasone—Infection—Capecitabine—prostate cancer	5.32e-05	0.00435	CcSEcCtD
Alclometasone—Desoximetasone—NR3C1—prostate cancer	5.29e-05	0.0286	CrCbGaD
Alclometasone—Loteprednol—NR3C1—prostate cancer	5.22e-05	0.0283	CrCbGaD
Alclometasone—Rash—Mitoxantrone—prostate cancer	5.04e-05	0.00412	CcSEcCtD
Alclometasone—Dermatitis—Mitoxantrone—prostate cancer	5.04e-05	0.00412	CcSEcCtD
Alclometasone—Beclomethasone—CYP3A5—prostate cancer	4.94e-05	0.0267	CrCbGaD
Alclometasone—Infection—Prednisone—prostate cancer	4.73e-05	0.00387	CcSEcCtD
Alclometasone—Pruritus—Etoposide—prostate cancer	4.7e-05	0.00385	CcSEcCtD
Alclometasone—Flurandrenolide—NR3C1—prostate cancer	4.63e-05	0.025	CrCbGaD
Alclometasone—Erythema—Epirubicin—prostate cancer	4.57e-05	0.00373	CcSEcCtD
Alclometasone—Flumethasone Pivalate—NR3C1—prostate cancer	4.55e-05	0.0246	CrCbGaD
Alclometasone—Halobetasol Propionate—NR3C1—prostate cancer	4.48e-05	0.0242	CrCbGaD
Alclometasone—Erythema—Doxorubicin—prostate cancer	4.23e-05	0.00346	CcSEcCtD
Alclometasone—Rash—Etoposide—prostate cancer	4.19e-05	0.00343	CcSEcCtD
Alclometasone—Dermatitis—Etoposide—prostate cancer	4.19e-05	0.00342	CcSEcCtD
Alclometasone—Budesonide—NR3C1—prostate cancer	4.16e-05	0.0225	CrCbGaD
Alclometasone—Mometasone—NR3C1—prostate cancer	3.96e-05	0.0214	CrCbGaD
Alclometasone—Rimexolone—NR3C1—prostate cancer	3.91e-05	0.0212	CrCbGaD
Alclometasone—Pruritus—Docetaxel—prostate cancer	3.91e-05	0.0032	CcSEcCtD
Alclometasone—Pruritus—Capecitabine—prostate cancer	3.79e-05	0.00309	CcSEcCtD
Alclometasone—Infection—Epirubicin—prostate cancer	3.7e-05	0.00303	CcSEcCtD
Alclometasone—Beclomethasone—NR3C1—prostate cancer	3.69e-05	0.02	CrCbGaD
Alclometasone—Fluocinolone Acetonide—NR3C1—prostate cancer	3.59e-05	0.0194	CrCbGaD
Alclometasone—Flunisolide—NR3C1—prostate cancer	3.49e-05	0.0189	CrCbGaD
Alclometasone—Clobetasol propionate—NR3C1—prostate cancer	3.49e-05	0.0189	CrCbGaD
Alclometasone—Rash—Docetaxel—prostate cancer	3.48e-05	0.00285	CcSEcCtD
Alclometasone—Dermatitis—Docetaxel—prostate cancer	3.48e-05	0.00285	CcSEcCtD
Alclometasone—Paramethasone—NR3C1—prostate cancer	3.45e-05	0.0187	CrCbGaD
Alclometasone—Infection—Doxorubicin—prostate cancer	3.43e-05	0.0028	CcSEcCtD
Alclometasone—Ciclesonide—NR3C1—prostate cancer	3.39e-05	0.0183	CrCbGaD
Alclometasone—Rash—Capecitabine—prostate cancer	3.37e-05	0.00276	CcSEcCtD
Alclometasone—Pruritus—Prednisone—prostate cancer	3.37e-05	0.00276	CcSEcCtD
Alclometasone—Dermatitis—Capecitabine—prostate cancer	3.37e-05	0.00276	CcSEcCtD
Alclometasone—Fluorometholone—NR3C1—prostate cancer	3.37e-05	0.0182	CrCbGaD
Alclometasone—Fluticasone Propionate—CYP3A5—prostate cancer	3.28e-05	0.0178	CrCbGaD
Alclometasone—Methylprednisolone—NR3C1—prostate cancer	3.25e-05	0.0176	CrCbGaD
Alclometasone—Dexamethasone—CYP17A1—prostate cancer	3.17e-05	0.0172	CrCbGaD
Alclometasone—Clobetasol propionate—CYP1A1—prostate cancer	3.17e-05	0.0172	CrCbGaD
Alclometasone—Rash—Prednisone—prostate cancer	3.01e-05	0.00246	CcSEcCtD
Alclometasone—Dermatitis—Prednisone—prostate cancer	3e-05	0.00245	CcSEcCtD
Alclometasone—Prednisolone—CYP2A6—prostate cancer	2.97e-05	0.0161	CrCbGaD
Alclometasone—Hydrocortisone—SHBG—prostate cancer	2.95e-05	0.016	CrCbGaD
Alclometasone—Betamethasone—CYP19A1—prostate cancer	2.77e-05	0.015	CrCbGaD
Alclometasone—Triamcinolone—NR3C1—prostate cancer	2.74e-05	0.0148	CrCbGaD
Alclometasone—Pruritus—Epirubicin—prostate cancer	2.64e-05	0.00216	CcSEcCtD
Alclometasone—Prednisone—NR3C1—prostate cancer	2.49e-05	0.0135	CrCbGaD
Alclometasone—Fluticasone Propionate—NR3C1—prostate cancer	2.45e-05	0.0133	CrCbGaD
Alclometasone—Pruritus—Doxorubicin—prostate cancer	2.44e-05	0.002	CcSEcCtD
Alclometasone—Budesonide—CYP3A4—prostate cancer	2.41e-05	0.013	CrCbGaD
Alclometasone—Rash—Epirubicin—prostate cancer	2.35e-05	0.00192	CcSEcCtD
Alclometasone—Hydrocortisone—CYP3A5—prostate cancer	2.35e-05	0.0127	CrCbGaD
Alclometasone—Dermatitis—Epirubicin—prostate cancer	2.35e-05	0.00192	CcSEcCtD
Alclometasone—Prednisolone—NR3C1—prostate cancer	2.29e-05	0.0124	CrCbGaD
Alclometasone—Prednisone—CYP2C19—prostate cancer	2.27e-05	0.0123	CrCbGaD
Alclometasone—Betamethasone—NR3C1—prostate cancer	2.25e-05	0.0122	CrCbGaD
Alclometasone—Dexamethasone—CYP1B1—prostate cancer	2.2e-05	0.0119	CrCbGaD
Alclometasone—Rash—Doxorubicin—prostate cancer	2.17e-05	0.00178	CcSEcCtD
Alclometasone—Dermatitis—Doxorubicin—prostate cancer	2.17e-05	0.00178	CcSEcCtD
Alclometasone—Flunisolide—CYP3A4—prostate cancer	2.02e-05	0.0109	CrCbGaD
Alclometasone—Paramethasone—CYP3A4—prostate cancer	2e-05	0.0108	CrCbGaD
Alclometasone—Ciclesonide—CYP3A4—prostate cancer	1.97e-05	0.0106	CrCbGaD
Alclometasone—Fluorometholone—CYP3A4—prostate cancer	1.95e-05	0.0106	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—CYP7B1—prostate cancer	1.92e-05	0.00119	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—prostate cancer	1.92e-05	0.00119	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—prostate cancer	1.91e-05	0.00118	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP7B1—prostate cancer	1.9e-05	0.00118	CbGpPWpGaD
Alclometasone—Methylprednisolone—CYP3A4—prostate cancer	1.89e-05	0.0102	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—SULT1E1—prostate cancer	1.87e-05	0.00116	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—prostate cancer	1.87e-05	0.00116	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IRS1—prostate cancer	1.86e-05	0.00115	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—prostate cancer	1.85e-05	0.00115	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—SULT1E1—prostate cancer	1.85e-05	0.00115	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NFIC—prostate cancer	1.84e-05	0.00114	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	1.84e-05	0.00114	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—prostate cancer	1.83e-05	0.00113	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—CYP1A1—prostate cancer	1.82e-05	0.00113	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—prostate cancer	1.82e-05	0.00113	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—prostate cancer	1.8e-05	0.00112	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—prostate cancer	1.8e-05	0.00112	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—prostate cancer	1.78e-05	0.00111	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—INS—prostate cancer	1.78e-05	0.0011	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—prostate cancer	1.76e-05	0.00109	CbGpPWpGaD
Alclometasone—Hydrocortisone—NR3C1—prostate cancer	1.75e-05	0.00949	CrCbGaD
Alclometasone—Dexamethasone—CYP3A5—prostate cancer	1.75e-05	0.00947	CrCbGaD
Alclometasone—NR3C1—Gene Expression—RPN2—prostate cancer	1.73e-05	0.00107	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—prostate cancer	1.73e-05	0.00107	CbGpPWpGaD
Alclometasone—NR3C1—Endoderm Differentiation—TGFB1—prostate cancer	1.73e-05	0.00107	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IGF1—prostate cancer	1.72e-05	0.00107	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—EP300—prostate cancer	1.71e-05	0.00106	CbGpPWpGaD
Alclometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	1.7e-05	0.00106	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—MYC—prostate cancer	1.7e-05	0.00105	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2A6—prostate cancer	1.69e-05	0.00917	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TGFB1—prostate cancer	1.69e-05	0.00105	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NPPA—prostate cancer	1.67e-05	0.00103	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—prostate cancer	1.66e-05	0.00103	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP3A5—prostate cancer	1.65e-05	0.00102	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—QARS—prostate cancer	1.64e-05	0.00102	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—MED12—prostate cancer	1.64e-05	0.00102	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—SERPINE1—prostate cancer	1.63e-05	0.00101	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP3A5—prostate cancer	1.63e-05	0.00101	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP19A1—prostate cancer	1.61e-05	0.00873	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA3—prostate cancer	1.59e-05	0.000988	CbGpPWpGaD
Alclometasone—Triamcinolone—CYP3A4—prostate cancer	1.59e-05	0.0086	CrCbGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—prostate cancer	1.58e-05	0.000977	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTA3—prostate cancer	1.57e-05	0.000974	CbGpPWpGaD
Alclometasone—Triamcinolone—PTGS2—prostate cancer	1.56e-05	0.00842	CrCbGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—prostate cancer	1.51e-05	0.000935	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	1.5e-05	0.000933	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—prostate cancer	1.5e-05	0.000932	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—TBX5—prostate cancer	1.5e-05	0.000932	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—prostate cancer	1.48e-05	0.000918	CbGpPWpGaD
Alclometasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—prostate cancer	1.47e-05	0.000913	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA4—prostate cancer	1.46e-05	0.000903	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—TBXAS1—prostate cancer	1.46e-05	0.000903	CbGpPWpGaD
Alclometasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—prostate cancer	1.45e-05	0.000901	CbGpPWpGaD
Alclometasone—Prednisone—CYP3A4—prostate cancer	1.44e-05	0.0078	CrCbGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTA4—prostate cancer	1.44e-05	0.000891	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—prostate cancer	1.43e-05	0.000886	CbGpPWpGaD
Alclometasone—Fluticasone Propionate—CYP3A4—prostate cancer	1.42e-05	0.00769	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA2—prostate cancer	1.42e-05	0.00088	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—SULT1A1—prostate cancer	1.4e-05	0.00087	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EIF3H—prostate cancer	1.4e-05	0.000866	CbGpPWpGaD
Alclometasone—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	1.39e-05	0.000863	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—SULT1A1—prostate cancer	1.38e-05	0.000858	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTA1—prostate cancer	1.37e-05	0.000849	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTO1—prostate cancer	1.35e-05	0.00084	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—NAT2—prostate cancer	1.35e-05	0.00084	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—NAT2—prostate cancer	1.34e-05	0.000828	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTO1—prostate cancer	1.34e-05	0.000828	CbGpPWpGaD
Alclometasone—Prednisolone—CYP3A4—prostate cancer	1.33e-05	0.00719	CrCbGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	1.31e-05	0.000811	CbGpPWpGaD
Alclometasone—Dexamethasone—NR3C1—prostate cancer	1.31e-05	0.00707	CrCbGaD
Alclometasone—Betamethasone—CYP3A4—prostate cancer	1.3e-05	0.00705	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2C18—prostate cancer	1.3e-05	0.000805	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2C18—prostate cancer	1.28e-05	0.000794	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CTNNB1—prostate cancer	1.28e-05	0.000791	CbGpPWpGaD
Alclometasone—Betamethasone—PTGS2—prostate cancer	1.28e-05	0.0069	CrCbGaD
Alclometasone—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	1.27e-05	0.00079	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.26e-05	0.000783	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.25e-05	0.000773	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.23e-05	0.000761	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—SULT2A1—prostate cancer	1.21e-05	0.000749	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2E1—prostate cancer	1.2e-05	0.00651	CrCbGaD
Alclometasone—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.2e-05	0.000741	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.19e-05	0.000741	CbGpPWpGaD
Alclometasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—prostate cancer	1.19e-05	0.00074	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP2C19—prostate cancer	1.19e-05	0.00644	CrCbGaD
Alclometasone—CYP3A4—Metapathway biotransformation—SULT2A1—prostate cancer	1.19e-05	0.000738	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP1A1—prostate cancer	1.19e-05	0.00642	CrCbGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.14e-05	0.000709	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MBD2—prostate cancer	1.14e-05	0.000706	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—TET2—prostate cancer	1.14e-05	0.000706	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GPX3—prostate cancer	1.14e-05	0.000704	CbGpPWpGaD
Alclometasone—CYP3A4—Tryptophan metabolism—MDM2—prostate cancer	1.12e-05	0.000697	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.12e-05	0.000696	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RPL12—prostate cancer	1.12e-05	0.000692	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—STAT3—prostate cancer	1.11e-05	0.000689	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.1e-05	0.000684	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.1e-05	0.000683	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—HPGDS—prostate cancer	1.08e-05	0.000671	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2C19—prostate cancer	1.08e-05	0.000667	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2C19—prostate cancer	1.06e-05	0.000658	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.06e-05	0.000655	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTT1—prostate cancer	1.05e-05	0.000651	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.05e-05	0.00065	CbGpPWpGaD
Alclometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.05e-05	0.000649	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2A6—prostate cancer	1.04e-05	0.000644	CbGpPWpGaD
Alclometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.04e-05	0.000642	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.03e-05	0.000639	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EIF3A—prostate cancer	1.03e-05	0.000636	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.02e-05	0.000635	CbGpPWpGaD
Alclometasone—Hydrocortisone—CYP3A4—prostate cancer	1.02e-05	0.0055	CrCbGaD
Alclometasone—CYP3A4—Metapathway biotransformation—AKR1C3—prostate cancer	9.96e-06	0.000618	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP17A1—prostate cancer	9.94e-06	0.000616	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP17A1—prostate cancer	9.81e-06	0.000608	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	9.71e-06	0.000602	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	9.49e-06	0.000589	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—NCOA2—prostate cancer	9.47e-06	0.000587	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	8.83e-06	0.000547	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	8.71e-06	0.00054	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DNMT3B—prostate cancer	8.63e-06	0.000535	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RPL10—prostate cancer	8.46e-06	0.000525	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	8.37e-06	0.000519	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	8.31e-06	0.000515	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	8.25e-06	0.000512	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GGT1—prostate cancer	8.11e-06	0.000503	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NPPA—prostate cancer	8.02e-06	0.000497	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HIST1H4H—prostate cancer	8.02e-06	0.000497	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	8.01e-06	0.000496	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—NCOA1—prostate cancer	7.98e-06	0.000495	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MED12—prostate cancer	7.89e-06	0.000489	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	7.87e-06	0.000488	CbGpPWpGaD
Alclometasone—NR3C1—Adipogenesis—IL6—prostate cancer	7.77e-06	0.000482	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	7.76e-06	0.000481	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—RXRA—prostate cancer	7.59e-06	0.000471	CbGpPWpGaD
Alclometasone—Dexamethasone—CYP3A4—prostate cancer	7.58e-06	0.0041	CrCbGaD
Alclometasone—Dexamethasone—PTGS2—prostate cancer	7.42e-06	0.00401	CrCbGaD
Alclometasone—CYP3A4—Biological oxidations—COMT—prostate cancer	7.31e-06	0.000454	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTP1—prostate cancer	7.28e-06	0.000451	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	7.25e-06	0.00045	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	7.21e-06	0.000447	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	7.18e-06	0.000445	CbGpPWpGaD
Alclometasone—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	6.71e-06	0.000416	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RPS19—prostate cancer	6.71e-06	0.000416	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—GSTM1—prostate cancer	6.69e-06	0.000415	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	6.6e-06	0.000409	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—DNMT1—prostate cancer	6.41e-06	0.000398	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	6.36e-06	0.000394	CbGpPWpGaD
Alclometasone—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	6.34e-06	0.000393	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NCOA2—prostate cancer	6.3e-06	0.00039	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HAO1—prostate cancer	6.26e-06	0.000388	CbGpPWpGaD
Alclometasone—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	6.26e-06	0.000388	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—EZH2—prostate cancer	6.21e-06	0.000385	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PARP1—prostate cancer	6.08e-06	0.000377	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	5.96e-06	0.00037	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—HSPA1A—prostate cancer	5.76e-06	0.000357	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ESR2—prostate cancer	5.76e-06	0.000357	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—NCOA1—prostate cancer	5.3e-06	0.000329	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ADI1—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CBR1—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TST—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PSAT1—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GRHL1—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CSAD—prostate cancer	5.1e-06	0.000316	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AR—prostate cancer	5.09e-06	0.000315	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—RXRA—prostate cancer	5.05e-06	0.000313	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GRHPR—prostate cancer	4.74e-06	0.000294	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.74e-06	0.000294	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CKMT2—prostate cancer	4.74e-06	0.000294	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.74e-06	0.000294	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SIRT1—prostate cancer	4.64e-06	0.000288	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—VDR—prostate cancer	4.57e-06	0.000283	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SULT2B1—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MBTPS1—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PGAM2—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—RFK—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NAGLU—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM3—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AOX1—prostate cancer	4.46e-06	0.000277	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP3A43—prostate cancer	4.23e-06	0.000262	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AMACR—prostate cancer	4.23e-06	0.000262	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—DEGS1—prostate cancer	4.23e-06	0.000262	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SRD5A2—prostate cancer	4.23e-06	0.000262	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NAT1—prostate cancer	4.23e-06	0.000262	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ERCC2—prostate cancer	4.18e-06	0.000259	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD17B1—prostate cancer	4.03e-06	0.00025	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—PPARA—prostate cancer	3.85e-06	0.000239	CbGpPWpGaD
Alclometasone—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	3.77e-06	0.000234	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.59e-06	0.000223	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HPGD—prostate cancer	3.59e-06	0.000223	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—ESR1—prostate cancer	3.49e-06	0.000217	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TNFRSF21—prostate cancer	3.38e-06	0.00021	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTAP—prostate cancer	3.29e-06	0.000204	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP7B1—prostate cancer	3.29e-06	0.000204	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SULT1E1—prostate cancer	3.2e-06	0.000199	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SRD5A1—prostate cancer	3.2e-06	0.000199	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—CREBBP—prostate cancer	3.06e-06	0.00019	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ACSL4—prostate cancer	3.06e-06	0.00019	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD17B3—prostate cancer	3.06e-06	0.00019	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UMPS—prostate cancer	2.93e-06	0.000182	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PHGDH—prostate cancer	2.93e-06	0.000182	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ARG2—prostate cancer	2.93e-06	0.000182	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LDHB—prostate cancer	2.87e-06	0.000178	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—SERPINE1—prostate cancer	2.87e-06	0.000178	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.82e-06	0.000175	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PDHA1—prostate cancer	2.72e-06	0.000169	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA3—prostate cancer	2.72e-06	0.000169	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TCN2—prostate cancer	2.72e-06	0.000169	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—UCP3—prostate cancer	2.72e-06	0.000169	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.6e-06	0.000161	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.6e-06	0.000161	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.49e-06	0.000154	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA4—prostate cancer	2.49e-06	0.000154	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA2—prostate cancer	2.43e-06	0.000151	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.4e-06	0.000149	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ABCG5—prostate cancer	2.4e-06	0.000149	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTA1—prostate cancer	2.34e-06	0.000145	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.32e-06	0.000144	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTO1—prostate cancer	2.32e-06	0.000144	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NAT2—prostate cancer	2.32e-06	0.000144	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PLCB2—prostate cancer	2.22e-06	0.000138	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.22e-06	0.000138	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LRP2—prostate cancer	2.22e-06	0.000138	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—P4HB—prostate cancer	2.18e-06	0.000135	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.12e-06	0.000131	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.06e-06	0.000128	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MED12—prostate cancer	2.03e-06	0.000126	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GNG5—prostate cancer	2.02e-06	0.000125	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA3—prostate cancer	1.94e-06	0.00012	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—HPGDS—prostate cancer	1.85e-06	0.000115	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.84e-06	0.000114	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—MYC—prostate cancer	1.82e-06	0.000113	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ACHE—prostate cancer	1.8e-06	0.000111	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTT1—prostate cancer	1.8e-06	0.000111	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.78e-06	0.00011	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.73e-06	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PRKACB—prostate cancer	1.72e-06	0.000107	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.7e-06	0.000105	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA2—prostate cancer	1.62e-06	0.0001	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.55e-06	9.58e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.51e-06	9.36e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NQO1—prostate cancer	1.49e-06	9.26e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TH—prostate cancer	1.47e-06	9.12e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.43e-06	8.87e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GGT1—prostate cancer	1.39e-06	8.59e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NCOA1—prostate cancer	1.37e-06	8.47e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.35e-06	8.34e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—RXRA—prostate cancer	1.3e-06	8.05e-05	CbGpPWpGaD
Alclometasone—NR3C1—Gene Expression—AKT1—prostate cancer	1.26e-06	7.81e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—COMT—prostate cancer	1.25e-06	7.76e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTP1—prostate cancer	1.25e-06	7.72e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ITPR1—prostate cancer	1.23e-06	7.6e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—TYMS—prostate cancer	1.16e-06	7.18e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—GSTM1—prostate cancer	1.14e-06	7.09e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—LPL—prostate cancer	1.12e-06	6.96e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.08e-06	6.72e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—ERCC2—prostate cancer	1.08e-06	6.67e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—MTHFR—prostate cancer	1.01e-06	6.27e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PPARA—prostate cancer	9.92e-07	6.15e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CAV1—prostate cancer	9.33e-07	5.78e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CG—prostate cancer	8.5e-07	5.27e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—INS—prostate cancer	8.04e-07	4.99e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—CREBBP—prostate cancer	7.88e-07	4.88e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CD—prostate cancer	7.47e-07	4.63e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—NOS3—prostate cancer	7.05e-07	4.37e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CB—prostate cancer	6.51e-07	4.04e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTGS2—prostate cancer	6.45e-07	4e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PTEN—prostate cancer	5.63e-07	3.49e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—EP300—prostate cancer	5.36e-07	3.33e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.97e-07	2.46e-05	CbGpPWpGaD
Alclometasone—CYP3A4—Metabolism—AKT1—prostate cancer	3.24e-07	2.01e-05	CbGpPWpGaD
